Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Biogen to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

Biogen Inc.
Posted on: 06 Sep 17

Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Morgan Stanley 15th Annual Global Healthcare Conference. The webcast will be live on Monday, September 11, 2017 at 11:05 a.m. ET. To access the live webcast, please visit Biogen’s Investors section at An archived version of the webcast will be available following the presentation.

About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. For more information, please visit Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

View source version on

Business Wire

Last updated on: 06/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.